The potential impact of the varicella vaccine and new antivirals on ocular disease related to varicella-zoster virus

American Journal of Ophthalmology

Volumn 123, Issue 2, 1997, Pages 243-251

  Pepose, J S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; ACICLOVIR; CHICKENPOX VACCINE; FAMCICLOVIR; SORIVUDINE; VALACICLOVIR;

ANTIVIRAL ACTIVITY; DRUG EFFECT; EYE DISEASE; INCIDENCE; PRIORITY JOURNAL; REVIEW; VARICELLA ZOSTER VIRUS; VIRUS INFECTION; VIRUS RESISTANCE;

EID: 0031013394     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(14)71042-6     Document Type: Article

References (75)

1. AE. Miller Selective decline in cellular immune response to varicella-zoster in the elderly Neurology 30 1980 582 587
2. R Berger G Florent M. Just Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged Infect Immun 32 1981 24 27
3. BL Burke RW Steele OW Beard JS Wood TD Cain DJ. Marmer Immune responses to varicella-zoster in the aged Arch Intern Med 142 1982 291 293
4. Centers for Disease Control and Prevention Mortality Patterns: United States, 1993 MMWR 45 1996 161 164
5. TH. Weller Varicella-zoster virus. History, perspectives, and evolving concerns Neurology 45 8,suppl 1995 S9 S10
6. MW Ragozzino LJ Melton III LT Kurland CP Chu HO. Perry Population-based study of herpes zoster and its sequelae Medicine 61 1982 310 316
7. JG Donahue PW Choo JE Manson R. Platt The incidence of herpes zoster Arch Intern Med 155 1995 1605 1609
8. K Schmader LK George BM Burchett CF Pieper JD. Hamilton Racial differences in the occurrence of herpes zoster J Infect Dis 171 1995 701 704
9. R Mahalingam M Wellish W Wolf Latent varicellazoster viral DNA in human trigeminal and thoracic ganglia N Engl J Med 323 1990 627 631
10. M Cobo GN Foulks TJ Liesegang Observations on the natural history of herpes zoster ophthalmicus Curr Eye Res 6 1987 195 199
11. L Womack TJ. Liesegang Complications of herpes zoster ophthalmicus Arch Ophthalmol 101 1983 42 45
12. M Karbassi MB Raizman JS. Schuman Herpes zoster ophthalmicus Surv Ophthalmol 36 1992 395 410
13. EV Sandor A Millman TS Croxson D. Mildvan Herpes zoster ophthalmicus in patients at risk for the acquired immune deficiency syndrome (AIDS) Am J Ophthalmol 101 1986 153 155
14. D Litoff RA. Catalano Herpes zoster optic neuritis in human immunodeficiency virus infection Arch Ophthalmol 108 1990 782 783
15. RE Engstrom GN. Holland Chronic herpes zoster virus keratitis associated with the acquired immunodeficiency syndrome Am J Ophthalmol 105 1988 556 558
16. WW Culbertson MS Blumenkranz JS Pepose JA Stewart VC. Curtin Varicella-zoster virus is a cause of the acute retinal necrosis syndrome Ophthalmology 93 1986 559 569
17. RE Engstrom GN Holland TP Margolis The progressive outer retinal necrosis syndrome: a variant of necrotizing herpetic retinopathy in patients with AIDS Ophthalmology 101 1994 1488 1502
18. A Urayama N Yamoda T Sasaki Unilateral acute uveitis with retinal periarteritis and detachment Jpn J Clin Ophthalmol 25 1971 607 629
19. GN Holland Standard diagnostic criteria for the acute retinal necrosis syndrome Am J Ophthalmol 177 1994 663 666 executive committee of the American Uveitis Society.
20. JS Duker MS. Blumenkranz Diagnosis and management of the acute retinal necrosis (ARN) syndrome Surv Ophthalmol 35 1991 327 343
21. DJ Browning MS Blumenkranz WW Culbertson Association of varicella-zoster dermatitis with acute retinal necrosis syndrome Ophthalmology 94 1987 602 606
22. JH Yeo JS Pepose JA Stewart P Sternberg RA. Liss Acute retinal necrosis syndrome following herpes zoster dermatitis Ophthalmology 93 1986 1418 1422
23. DJ Forster PU Dugel GT Frangieh PE Liggett NA. Rao Rapidly progressive outer retinal necrosis in the acquired immunodeficiency syndrome Am J Ophthalmol 110 1990 341 348
24. JJ O'Brien DM. Campoli-Richards Acyclovir: an updated review of its antiviral activity, pharmacokinetic properties, and therapeutic efficacy Drugs 37 1989 233 309
25. JC. Huff Oral acyclovir therapy of acute herpes zoster: a multi-centre study Res Clin Forums 9 1987 37 45
26. P Morton AN. Thomas Oral acyclovir in the treatment of herpes zoster in general practice N Z Med J 102 1989 93 95
27. MW McKendrick JI McGill JE White MJ. Wood Oral acyclovir in acute herpes zoster Br Med J 293 1986 1529 1532
28. LM Cobo GN Foulks TJ Liesegang Oral acyclovir in the treatment of acute herpes zoster ophthalmicus Ophthalmology 93 1986 763 770
29. SP Harding SM. Porter Oral acyclovir in herpes zoster ophthalmicus Curr Eye Res 10 suppl 1991 177 182
30. SP Harding JR Lipton JCD. Wells Natural history of herpes zoster ophthalmicus: predictors of post-herpetic neuralgia and ocular involvement Br J Ophthalmol 71 1987 353 358
31. T Hoang-Xuan ER Bchi CP Herbort Oral acyclovir for herpes zoster ophthalmicus Ophthalmology 99 1992 1062 1071
32. CP Herbort ER Buechi B. Piguet Zografos L, Fitting P High-dose oral acyclovir in acute herpes zoster ophthalmicus: the end of the corticosteroid era. Curr Eye Res 10 suppl 1991 171 175
33. GW Aylward CMP Claou RJ Marsh N. Yasseem Influence of oral acyclovir on ocular complications of herpes zoster ophthalmicus Eye 8 1994 70 74
34. JI McGill JE. White Acyclovir and post-herpetic neuralgia and ocular involvement Br Med J 309 1994 1124
35. MS Blumenkranz WW Culbertson JG Clarkson R. Dix Treatment of the acute retinal necrosis syndrome with intravenous acyclovir Ophthalmology 93 1986 296 300
36. DA Palay Sternberg P Jr J. Davis Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy Am J Ophthalmol 112 1991 250 255
37. JS Pepose K. Biron Antiviral sensitivities of the acute retinal necrosis syndrome Curr Eye Res 6 1987 201 205
38. DR Burdge R Voigt JI Lindley L Gage SL. Sacks Sorivudine (BV-ara-U) for the treatment of complicated refractory varicella-zoster virus infection in HIV-infected patients AIDS 9 1995 810 812
39. WH Johnston GN Holland RE Engstrom Jr S. Rimmer Recurrence of presumed varicella-zoster virus retinopathy in patients with acquired immunodeficiency syndrome Am J Ophthalmol 116 1993 42 50
40. MG Morley JS Duker C. Zacks Successful treatment of rapidly progressive outer retinal necrosis in the acquired immunodeficiency syndrome Am J Ophthalmol 117 1994 264 265
41. DM Laby FP Nasrallah SI Butrus PV. Whitmore Treatment of outer retinal necrosis in AIDS patients Graefes Arch Clin Exp Ophthalmol 231 1993 271 273
42. CL Talarico WC Phelps KK. Biron Analysis of the thymidine kinase genes from acyclovir-resistant mutants of varicella virus isolated from patients with AIDS J Virol 67 1993 1024 1033
43. S Safrin TG Berger I Gilson Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella-zoster virus infection Ann Intern Med 115 1991 19 21
44. S Weller MR Blum M Doucette Pharmacoklnetics of the acyclovir pro-drug, valaciclovir after escalating single-and multiple-dose administration to normal volunteers Clin Pharmacol Ther 54 1993 595 605
45. KR Beutner DJ Friedman C Forszpaniak PL Andersen MJ. Wood Valaciclovir compared with acyclovir for improved therapy for herpes zoster immunocompetent adults Antimicrob Agents Chemother 39 1995 1546 1553
46. CM Perry M. Wagstaff Famciclovir: a review of its pharmacological properties and therapeutic efficacy in herpesvirus infections Drugs 50 1995 396 415
47. H. deGreef Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients Int J Antimicrob Agents 4 1995 241 246
48. S Tyring RA Barbarash JE Nahlik Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia Ann Intern Med 123 1995 89 96 and the Collaborative Famciclovir Herpes Zoster Study Group.
49. RJ. Whitley Sorivudine: a promising drug for the treatment of varicella-zoster virus infection Neurology 45 8,suppl 1995 S73 S75
50. H Machida S. Sakata In vitro and in vivo antiviral activity of I-β-d-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-araU) and related compounds Antiviral Res 4 1984 135 141
51. C Desgranges G Razaka E De Clercq Effect of (E)-5-(2-Bromovinyl) uracil on the catabolism and antitumor activity of 5-fluorouracil in rats and leukemic mice Cancer Res 46 1986 1094 1101
52. H Sato H Oh R Cho H Nakamura T. Asai Successful treatment of sorivudine-related agranulocytosis with granulocyte colony-stimulating factor Am J Hematol 50 1995 227
53. MK Pinnolis D Foxworthy B. Kemp Treatment of progressive outer retinal necrosis with sorivudine Am J Ophthalmol 119 1995 516 517
54. P Wutzler E De Clercq K Wutke I. Farber Oral brivudin vs intravenous acyclovir in the treatment of herpes zoster in immunocompromised patients: a randomized double-blind trial J Med Virol 46 1995 252 257
55. M Heidi H Scholz W Dorffel J. Hermann Antiviral therapy of varicella-zoster virus infection in immunocompromised children: a prospective randomized study of acyclovir versus brivudin Infection 19 1991 401 405
56. TP Sellitti AJW Huang J Schiffman JL. Davis Association of herpes zoster ophthalmicus with acquired immunodeficiency syndrome and acute retinal necrosis Am J Ophthalmol 116 1993 297 301
57. MA Jacobson TG Berger S Fikrig Acyclovir-resistant varicella-zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS) Ann Intern Med 112 1990 187 191
58. AM Fillet B Visse E Caumes B Dumont M Gentilini JM. Huraux Foscarnet-resistant multidermatomal zoster in a patient with AIDS Clin Infect Dis 21 1995 1348 1349
59. Centers for Disease Control and Prevention Licensure of varicella virus vaccine, live MMWR 44 1995 264
60. M Takahashi T Otsuka Y Okuno Y Asano T Yazaki S. Isomura Live vaccine used to prevent the spread of varicella in children in hospital Lancet 2 1974 1288 1290
61. RW. Ellis Varicella vaccine Vaccine 13 1995 1387 1388
62. AA. Gershon Varicella vaccine: its past, present and future Pediatr Infect Dis J 14 1995 742 744
63. SA. Plotkin Varicella vaccine Pediatrics 97 1996 251 253
64. Y Uchida M Kaneko K. Hayashi Varicella dendritic keratitis Am J Ophthalmol 89 1980 259 262
65. SR Lambert D Taylor A Kriss H Holzel S. Heard Ocular manifestations of the congenital varicella syndrome Arch Ophthalmol 107 1989 52 56
66. AA Gershon S Projansky Steinberg Live attenuated varicella vaccine: efficacy for children with leukemia in remission JAMA 252 1984 355 362 and the N.I.A.I.D Varicella Vaccine Collaborative Study Group.
67. I Hardy AA Gershon SP Steinberg P LaRussa The incidence of zoster after immunization with live attenuated varicella vaccine: a study in children with leukemia N Engl J Med 325 1991 1545 1550 and the Varicella Vaccine Collaborative Study Group.
68. PA Brunell J Taylor-Wiedeman CF Geiser L Frierson E. Lydick Risk of herpes zoster in children with leukemia: varicella vaccine compared with history of chickenpox Pediatrics 77 1986 53 56
69. CJ. White Letter to the editor Pediatrics 89 1992 354
70. K Matsubara II Nigami H Harigaya K. Baba Herpes zoster in a normal child after varicella vaccination Acta Paediatrica Japonica 37 1995 648 650
71. MN. Oxman Immunization to reduce the frequency and severity of herpes zoster and its complications Neurology 45 8,suppl 1995 541 546
72. A. Gershon Varicella-zoster virus: prospects for control Adv Pediatr Infect Dis 10 1995 93 124
73. BJ Kuter RE Weibel HA Guess Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies Vaccine 9 1991 643 647
74. Y Asano S Suga T Yoshikawa Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine Pediatrics 94 1994 524 526
75. A. Vafai Boosting immune response with a candidate varicella-zoster virus glycoprotein subunit vaccine Vaccine 13 1995 1336 1338